关注
Graziella Madeo
Graziella Madeo
在 med.uniroma2.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: a consensus paper on the present state of the science and the road ahead
H Ekhtiari, H Tavakoli, G Addolorato, C Baeken, A Bonci, S Campanella, ...
Neuroscience & Biobehavioral Reviews 104, 118-140, 2019
2612019
Early synaptic dysfunction in Parkinson's disease: insights from animal models
T Schirinzi, G Madeo, G Martella, M Maltese, B Picconi, P Calabresi, ...
Movement Disorders 31 (6), 802-813, 2016
1602016
Centrality of striatal cholinergic transmission in basal ganglia function
P Bonsi, D Cuomo, G Martella, G Madeo, T Schirinzi, F Puglisi, G Ponterio, ...
Frontiers in Neuroanatomy 5, 2011
1402011
Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic
M Bikson, CA Hanlon, AJ Woods, BT Gillick, L Charvet, C Lamm, ...
Brain stimulation 13 (4), 1124-1149, 2020
1142020
Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia
G Sciamanna, A Tassone, G Mandolesi, F Puglisi, G Ponterio, G Martella, ...
Journal of Neuroscience 32 (35), 11991-12004, 2012
1112012
Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1 muscarinic receptors
M Maltese, G Martella, G Madeo, I Fagiolo, A Tassone, G Ponterio, ...
Movement disorders 29 (13), 1655-1665, 2014
972014
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia
G Martella, M Maltese, R Nistico, T Schirinzi, G Madeo, G Sciamanna, ...
Neurobiology of disease 65, 124-132, 2014
942014
Pisa syndrome in Parkinson disease: an observational multicenter Italian study
M Tinazzi, A Fasano, C Geroin, F Morgante, R Ceravolo, S Rossi, ...
Neurology 85 (20), 1769-1779, 2015
912015
Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia
G Sciamanna, A Tassone, G Martella, G Mandolesi, F Puglisi, D Cuomo, ...
PloS one 6 (9), e24261, 2011
892011
Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatment
D Cuomo, G Martella, E Barabino, P Platania, D Vita, G Madeo, C Selvam, ...
Journal of neurochemistry 109 (4), 1096-1105, 2009
892009
Basal ganglia and beyond: the interplay between motor and cognitive aspects in Parkinson’s disease rehabilitation
D Ferrazzoli, P Ortelli, G Madeo, N Giladi, GM Petzinger, G Frazzitta
Neuroscience & Biobehavioral Reviews 90, 294-308, 2018
812018
Homeostatic changes of the endocannabinoid system in Parkinson's disease
V Pisani, G Madeo, A Tassone, G Sciamanna, M Maccarrone, ...
Movement disorders 26 (2), 216-222, 2011
632011
PINK1 heterozygous mutations induce subtle alterations in dopamine‐dependent synaptic plasticity
G Madeo, T Schirinzi, G Martella, EC Latagliata, F Puglisi, J Shen, ...
Movement Disorders 29 (1), 41-53, 2014
562014
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice
G Martella, G Madeo, M Maltese, V Vanni, F Puglisi, E Ferraro, T Schirinzi, ...
Neurobiology of Disease 91, 21-36, 2016
522016
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain
G Madeo, T Schirinzi, S Natoli, M Pierantozzi, A Stefani, M Dauri, A Pisani
Journal of neurology 262, 2164-2170, 2015
502015
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus
T Schirinzi, GM Sancesario, C Ialongo, P Imbriani, G Madeo, S Toniolo, ...
Frontiers in neurology 6, 86, 2015
502015
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission
A Tassone, G Madeo, T Schirinzi, D Vita, F Puglisi, G Ponterio, F Borsini, ...
Neuropharmacology 61 (4), 632-637, 2011
482011
Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice
H Shen, RAM Marino, RA McDevitt, GH Bi, K Chen, G Madeo, PT Lee, ...
Proceedings of the National Academy of Sciences 115 (49), E11532-E11541, 2018
412018
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia
G Sciamanna, G Ponterio, A Tassone, M Maltese, G Madeo, G Martella, ...
Neuropharmacology 85, 440-450, 2014
402014
Distinct roles of group I mGlu receptors in striatal function
P Bonsi, P Platania, G Martella, G Madeo, D Vita, A Tassone, G Bernardi, ...
Neuropharmacology 55 (4), 392-395, 2008
342008
系统目前无法执行此操作,请稍后再试。
文章 1–20